Global Afoxolaner Chewable Tablets Market Growth 2025-2031

The global Afoxolaner Chewable Tablets market size is predicted to grow from US$ 1415 million in 2025 to US$ 2707 million in 2031; it is expected to grow at a CAGR of 11.4% from 2025 to 2031.

Meaning Afoxolaner"s chewable tablets

United States market for Afoxolaner Chewable Tablets is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Afoxolaner Chewable Tablets is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Afoxolaner Chewable Tablets is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Afoxolaner Chewable Tablets players cover Merial Toulouse, Boehringer Ingelheim, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Afoxolaner Chewable Tablets Industry Forecast” looks at past sales and reviews total world Afoxolaner Chewable Tablets sales in 2024, providing a comprehensive analysis by region and market sector of projected Afoxolaner Chewable Tablets sales for 2025 through 2031. With Afoxolaner Chewable Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Afoxolaner Chewable Tablets industry.

This Insight Report provides a comprehensive analysis of the global Afoxolaner Chewable Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Afoxolaner Chewable Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Afoxolaner Chewable Tablets market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Afoxolaner Chewable Tablets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Afoxolaner Chewable Tablets.

This report presents a comprehensive overview, market shares, and growth opportunities of Afoxolaner Chewable Tablets market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Afoxolaner Chewable Tablets
Afoxolaner and Milbemycin Oxime Chewable Tablets

Segmentation by Application:
Tick Infection in Dogs
Gastrointestinal Nematode Infection in Dogs
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Merial Toulouse
Boehringer Ingelheim

Key Questions Addressed in this Report

What is the 10-year outlook for the global Afoxolaner Chewable Tablets market?

What factors are driving Afoxolaner Chewable Tablets market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Afoxolaner Chewable Tablets market opportunities vary by end market size?

How does Afoxolaner Chewable Tablets break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.